BackAkari Therapeutics Plc Overview

Akari Therapeutics Plc Goodwill

Track Akari Therapeutics Plc's goodwill ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00
100.00% YoYΔ $-8.43M vs prior year quarter

Peer trimmed avg / median

Loading

Akari Therapeutics Plc Goodwill History

Loading

Akari Therapeutics Plc vs. peers: Goodwill Comparison

Loading

Akari Therapeutics Plc Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Akari Therapeutics Plc (AKTX) FAQ

The latest goodwill for AKTX is $0 as of June 2026. That compares with $8.4M in the prior-year period — down 100.0% year over year. Investors often review this figure alongside Akari Therapeutics Plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, AKTX's goodwill moved from $8.4M to $0 — a 100.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Akari Therapeutics Plc's operating scale or balance-sheet position.

A goodwill figure of $0 for AKTX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting AKTX's goodwill ($0), review year-over-year change from $8.4M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Akari Therapeutics Plc's goodwill against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.